NCT06386354|Recruiting
Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications
Porcerito
Loading search results
Porcerito
Sponsor study identifier
observational
296
1 country
2
Study Start
May 1, 2024
Actual (reported)Primary Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 23, 2024
Actual (reported)April 26, 2024
Actual (reported)May 1, 2024
Actual (reported)October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Residual Neuromuscular Block
Train-Of-Four ratio at arrival to the Post-Anesthetic Care Unit
5 minutes postoperatively
Residual Neuromuscular Block
Train-Of-Four ratio 3 minutes after the arrival to the Post-Anesthetic Care Unit
8 minutes postoperatively
Postoperative complications
30 days postoperatively
Patients submitted to General Anesthesia with Neuromuscular Block
Patients submitted to general anesthesia with neuromuscular block will be monitored at their arrival to the Post-Anesthesia Care Unit to assess the presence of residual neuromuscular block.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time.
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Las Palmas, 35010, Spain
Ángel Becerra
Las Palmas de Gran Canaria, Las Palmas, 35019, Spain
First Submitted
April 23, 2024
First Posted
April 26, 2024
Study Start
May 1, 2024
Actual (reported)Primary Completion
October 30, 2025
Estimated (date passed)Enhanced Recovery After Urogynaecological Surgery - Early Urinary Catheter Removal in an Asian Population
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 24, 2025
Record last verified: 2025-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: